Centro de Investigación Biomédica en Red sobre Enfermedades Raras -ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2023

  1. P-Rex1 is a novel substrate of the E3 ubiquitin ligase Malin associated with Lafora disease

    Neurobiology of Disease, Vol. 177

2022

  1. Multiple ciliary localization signals control INPP5E ciliary targeting

    eLife, Vol. 11

2020

  1. Structural and functional brain abnormalities in mouse models of lafora disease

    International Journal of Molecular Sciences, Vol. 21, Núm. 20, pp. 1-15

2019

  1. Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome

    Neurobiology of Disease, Vol. 127, pp. 210-222

2018

  1. Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors

    Nature Reviews Cardiology, Vol. 15, Núm. 12, pp. 731-743

2017

  1. 4-Phenylbutyric acid and metformin decrease sensitivity to pentylenetetrazol-induced seizures in a malin knockout model of Lafora disease

    NeuroReport, Vol. 28, Núm. 5, pp. 268-271

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Synaptic plasticity and spatial working memory are impaired in the CD mouse model of Williams-Beuren syndrome

    Molecular Brain, Vol. 9, Núm. 1

2013

  1. Targeting the endocannabinoid system in the treatment of fragile X syndrome

    Nature Medicine, Vol. 19, Núm. 5, pp. 603-607

2010

  1. Estudios Farmacogenéticos del tratamiento con Antipsicóticos: Estado actual y perspectivas

    Actas Espanolas de Psiquiatria, Vol. 38, Núm. 5, pp. 301-316